I think the financial state is heavily dependent on whether or not Novartis continues with the collaboration/licensing agreement. The 90 day extension to the cooling off period due to the failed Covid trial revealed by Novartis but not yet acknowledged by SI is not that far from expiry.
That may eventually trigger a reaction.
Funding MSB, page-71
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $4.638M | 5.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 152669 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 51069 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |